Momenta Pharmaceuticals Articles
Watson settles over Exalgo; gets favorable news on enoxaparin
29 January 2012
Baxter taps Momenta expertise on biosimilars
28 December 2011
Watson temporarily restrained from marketing generic Lovenox; challenges Pfizer’s Embeda patent
10 October 2011
US Supreme Court agrees to hear generic drug labelling case; Teva files to stop generic Copaxone
13 December 2010
Momenta Pharma sues Teva for enoxaparin patent infringement
3 December 2010
Showing 1-8 of 8 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
